Cyclin E1 and Rb modulation as common events at time of resistance to palbociclib in hormone receptor-positive breast cancer

Cristina Guarducci, Martina Bonechi, Matteo Benelli, Chiara Biagioni, Giulia Boccalini, Dario Romagnoli, Roberto Verardo, Rachel Schiff, Charles Kent Osborne, Carmine De Angelis, Angelo Di Leo, Luca Malorni, Ilenia Migliaccio
ISSN / E-ISSN
— / —
DOI
10.1038/s41523-018-0092-4 ↗
Volume · Issue · Pages
4 · 1 · 38-38
Publisher
Nature Publishing Group
Article URL
https://doi.org/10.1038/s41523-018-0092-4 ↗
Article details
Unverified
Publication date (each date has its type and source)
22 Nov 2018
OpenAlex publication date · source: OpenAlex
Dates on record for this article
TypeDateSource
OpenAlex publication date22 Nov 2018 OpenAlex

Keywords (as given): palbociclib resistance; CDK4/6 inhibitors; hormone receptor-positive breast cancer; cyclin E1; RB1; E2F target genes; prognostic factors; estrogen receptor-positive breast cancer; neoadjuvant therapy

HEC Status at Publication Not the journal's current status

HEC Status at PublicationNot conclusive
Best available information, not a definitive status: HEC status cannot be determined for this date: no HEC list is recorded as in effect on it.
Journal
npj Breast Cancer
Publication date used
22 Nov 2018 (OpenAlex publication date)
Applicable HEC period
None recorded for this date
Category
—
Recognition status
Unknown (NO_PERIOD_FOR_DATE)
Source
—
Verification status
Not available
This is an automatically generated summary based on the information available on the publication date. Terms & conditions apply.